Live Breaking News & Updates on Richard Vosser|Page 4

Stay updated with breaking news from Richard vosser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

JPMorgan rates Bayer at 'Neutral' - Target 34 euros

The US bank JPMorgan has left its rating for Bayer at Neutral with a target price of 34 euros ahead of the company s figures for the first quarter. After expectations have recently been put on a new. ....

Richard Vosser ,

6 Stocks Positioned to Soar as Investors Focus on MASH

Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it s easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class. ....

Richard Vosser , Mark Mckelvie , Bristol Myers Squibb , Razorpitch Inc , Bioxytran Inc , Bio Inc , Madrigal Pharmaceuticals , Jp Morgan , Company Website , Galectin Therapeutics , Fite Biopharma , Private Securities Litigation Reform Act , Pitch Inc ,

SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating

Richard Vosser from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price is still set at EUR 365. ....

Richard Vosser , Jp Morgan ,

NOVARTIS AG : Gets a Neutral rating from JP Morgan -April 03, 2024 at 04:40 am EDT

In a research note published by Richard Vosser, JP Morgan gives a Neutral rating to the stock. The target price is unchanged and still at CHF 90. ....

Richard Vosser , Jp Morgan ,

ROCHE HOLDINGS AG : Gets a Sell rating from JP Morgan -April 02, 2024 at 03:24 am EDT

Richard Vosser from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is still set at CHF 210. ....

Richard Vosser , Jp Morgan ,